Roche calls offer for Illumina "starting point"
(Reuters) - Swiss drugmaker Roche Holding AG, in a letter to Illumina Inc shareholders, called its sweetened $51-a-share offer for the maker of genetic analysis equipment "a more than reasonable starting point for negotiations."
Roche calls offer for Illumina "starting...
Computer Store VirtueMart 2...
Starting The Dukan Diet
Find us on Google+